Research and Innovation

2022 International Consortium for Antimicrobial Stewardship (ICASA) in Agriculture Funding Opportunity

The International Consortium for Antimicrobial Stewardship in Agriculture (ICASA) – is soliciting Letters of Intent (LOI) for research concepts for potential funding and collaboration. ICASA, a public-private partnership, is focused on antibiotic stewardship in animal agriculture and has committed to investing in research to accelerate innovation and antibiotic stewardship across the livestock supply chain.

Grants to support innovation pilots in developing country contexts

DIV provides funding in three tiered stages and also provides funding for researchers seeking to generate rigorous evidence. Organizations should apply to the level that best matches their current scale and evidence base of impact and cost-effectiveness. Organizations may apply again for the same level of funding or another level of funding.

Funder: US Agency for International Development

UrL: https://www.usaid.gov/div/about

Dateline: Rolling

Chemical Security Improvement Grants

On behalf of the U.S. Department of State’s Chemical Security Program (CSP), CRDF Global is pleased to offer grants to improve the physical and procedural security of chemical laboratories and facilities. These Chemical Security Improvement Grants (CSIG) contribute to the security of industrial and academic chemical facilities, including their employees and their communities, and aim to prevent the accidental or intentional misuse of chemicals. CSIGs are one-time awards ranging from $2,000 to $30,000 in value with applications accepted on a quarterly basis.

Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) solicits R01 research projects that seek to investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations (PAIRS) program is to develop radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments.

Funder: National Institute of Health

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors.

Market-aligned interventions for cleaner production in the textiles value chain, in South Asia and sub-Saharan Africa

Implementation-focused projects that prove the viability of, or pilot, solutions in commercial value chains, that address problematic practices in this sector, including but not limited to excessive consumption of raw materials, water, and energy; and generation and poor management of liquid effluents and solid waste. Projects should bring together the following parties:

Leakey Foundation Grants related to human origins

The Leakey Foundation exclusively funds research related to human origins. Priority of funding is commonly given to exploratory phases of promising new research projects that meet the stated purpose of the Foundation. The majority of The Leakey Foundation’s Research Grants awarded to doctoral students are in the $3,000-$15,000 range with a funding limit of $20,000. Larger grants given to senior scientists and post-doctoral researchers may be funded up to $30,000.

Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications on the development and testing of behavioral and integrative treatments for drug and alcohol use, abuse, and dependence. This FOA reaffirms the continued commitment of NIDA to major programs of research on behavioral and integrative treatments. The term "behavioral treatments" is used here in a broad sense and includes but is not limited to psychotherapies, cognitive, relapse prevention, remediative, rehabilitative, skills training, counseling, family, and exercise therapies.

NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)

The goal of this funding opportunity announcement is to support meritorious research projects that involve secondary data analyses of existing oral or craniofacial database resources, or that develop needed statistical methodology for analyzing existing dental, oral or craniofacial databases.

Funder: National Institute of Health

URL: https://grants.nih.gov/grants/guide/pa-files/PAR-22-160.html

Deadline: October 16, 2023, February 16, 2023

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for innovative informatics methods and algorithms to improve the acquisition, analysis, visualization, or interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities.